163 related articles for article (PubMed ID: 2996799)
1. High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung.
Cunningham D; Banham SW; Hutcheon AH; Dorward A; Ahmedzai S; Tansey P; Soukop M; Stevenson RD; Stack BR; Kaye SB
Cancer Chemother Pharmacol; 1985; 15(3):303-6. PubMed ID: 2996799
[TBL] [Abstract][Full Text] [Related]
2. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
[TBL] [Abstract][Full Text] [Related]
3. High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
Spitzer G; Farha P; Valdivieso M; Dicke K; Zander A; Vellekoop L; Murphy WK; Dhingra HM; Umsawasdi T; Chiuten D
J Clin Oncol; 1986 Jan; 4(1):4-13. PubMed ID: 3510281
[TBL] [Abstract][Full Text] [Related]
4. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
5. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Collins C; Higano CS; Livingston RB; Griffin BR; Keppen MD; Miller TP
Cancer Chemother Pharmacol; 1989; 24(2):128-32. PubMed ID: 2543513
[TBL] [Abstract][Full Text] [Related]
7. Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation.
Sculier JP; Klastersky J; Stryckmans P
J Clin Oncol; 1985 Feb; 3(2):184-91. PubMed ID: 2981983
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
9. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens.
Lowenbraun S; Birch R; Buchanan R; Krauss S; Durant J; Perez C; Mill W; Vollmer R; Ogden L
Cancer; 1984 Dec; 54(11):2344-50. PubMed ID: 6093979
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Donnelly EJ; Raub WA
Am J Clin Oncol; 1994 Dec; 17(6):527-37. PubMed ID: 7977175
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer.
Souhami RL; Hajichristou HT; Miles DW; Earl HM; Harper PG; Ash CM; Goldstone AH; Spiro SG; Geddes DM; Tobias JS
Cancer Chemother Pharmacol; 1989; 24(5):321-5. PubMed ID: 2547528
[TBL] [Abstract][Full Text] [Related]
14. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
[TBL] [Abstract][Full Text] [Related]
15. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
16. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
18. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
Jackson DV; Zekan PJ; Caldwell RD; Slatkoff ML; Harding RW; Case LD; Hopkins JO; Muss HB; Richards F; White DR
J Clin Oncol; 1984 Dec; 2(12):1343-51. PubMed ID: 6096517
[TBL] [Abstract][Full Text] [Related]
19. Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer.
Natale RB; Shank B; Hilaris BS; Wittes RE
Am J Med; 1985 Sep; 79(3):303-8. PubMed ID: 2994472
[TBL] [Abstract][Full Text] [Related]
20. Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.
Goodman GE; Miller TP; Manning MM; Davis SL; McMahon LJ
J Clin Oncol; 1983 Aug; 1(8):483-8. PubMed ID: 6321685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
